BRIGHT MINDS BIOSCIENCES INC. (DRUG)
search
Earnings reactions
How DRUG moved on each past earnings report.
Up
Down
Earnings Impact
BRIGHT MINDS BIOSCIENCES INC. (DRUG) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
BRIGHT MINDS BIOSCIENCES INC. (DRUG) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 17 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
17
Funds holding
$172845649
Total value held
Buying
16 added · 1 reduced
Janus Henderson Group Plc
$93518052
NEW BUY
Blackrock, Inc.
$48170117
+10.33%
Goldman Sachs Group Inc
$9384968
+79.76%
State Street Corp
$8576896
+12.88%
Northern Trust Corp
$2981114
+13.61%
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 6-K | 20260817 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| S-8 | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260812 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260702 | open_in_new SEC.gov |
| 6-K | 20260603 | open_in_new SEC.gov |
| 6-K | 20260602 | open_in_new SEC.gov |
| 6-K | 20260528 | open_in_new SEC.gov |
| 6-K | 20260520 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |